A novel, high-throughput, nanotopographic platform for screening cell migratory behavior

US2017016884A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2017016884-A1
Application numberUS-201515125041-A
CountryUS
Kind codeA1
Filing dateMar 10, 2015
Priority dateMar 10, 2014
Publication dateJan 19, 2017
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is directed to creating a highly versatile, high throughput, and convenient platform for interrogating migration phenotypes of GB cells in the context of diverse environmental parameters. Specifically, engineered substrates are employed to mimic the mechanical signals of natural ECM topography, and combine these tools with chemical cues presented in soluble and immobilized forms (PDGF and laminin, respectively). This platform achieves far greater resolution and sensitivity in migration analyses than do commonly used methods. More importantly, it can provide highly informative, patient specific results regarding tumor progression in vivo. Furthermore these capabilities strongly convey the immense clinical, prognostic potential of this simple test.

First claim

Opening claim text (preview).

1 . A device for cell migration comprising: a multi-well plate having a number of well chambers, wherein the well chambers comprise at least one wall defining the well chamber; a nanopatterned surface, wherein the nanopatterned surface is positioned on the at least one wall defining the well chamber; wherein the nanopatterened surface is configured to mimic the topographic structure of a natural cell environment. 2 . The device for cell migration of claim 1 wherein the nanopatterned surface further comprises parallel ridges. 3 . The device for cell migration of claim 2 wherein the parallel ridges are approximately 350 nm wide and approximately 500 nm high and spaced apart 1.5 μm. 4 . The device for cell migration of claim 1 wherein the nanopatterned surface is formed directly into the at least one wall defining the well chamber. 5 . The device for cell migration of claim 1 wherein the nanopatterened surface is formed onto a glass coverslip. 6 . The device for cell migration of claim 1 wherein the nanopatterned surface is configured to mimic the mechanical signals of natural ECM topography. 7 . The device for cell migration of claim 6 wherein the nanopatterned surface configured to mimic the mechanical signals of natural ECM topography is combined with chemical cues. 8 . The device for cell migration of claim 7 wherein the chemical cues are soluble. 9 . The device for cell migration of claim 7 wherein the chemical cues are immobilized. 10 . The device for cell migration of claim 1 further comprising a coating of laminin. 11 . The device for cell migration of claim 10 further comprising varying the concentration of laminin in the coating. 12 . The device for cell migration of claim 1 further comprising a coating of platelet derived growth factor (PDGF). 13 . The device for cell migration of claim 12 further comprising varying the concentration of PDGF in the coating. 14 . The device for cell migration of claim 1 further comprising configuring the device for cell migration to test migration of glioblastoma. 15 . The device for cell migration of claim 1 further comprising configuring the device to provide patient-specific results regarding tumor progression. 16 . The device for cell migration further comprising configuring the device for diagnosis of brain tumors.

Assignees

Inventors

Classifications

  • of other specific parts of the body, e.g. brain · CPC title

  • for cancer · CPC title

  • Nanoscaled · CPC title

  • Slides · CPC title

  • of solid biological material, e.g. tissue samples, cell cultures (tissue in vivo A61B5/00; cell suspensions G01N33/48735) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2017016884A1 cover?
The present invention is directed to creating a highly versatile, high throughput, and convenient platform for interrogating migration phenotypes of GB cells in the context of diverse environmental parameters. Specifically, engineered substrates are employed to mimic the mechanical signals of natural ECM topography, and combine these tools with chemical cues presented in soluble and immobilized…
Who is the assignee on this patent?
Univ Johns Hopkins
What technology area does this patent fall under?
Primary CPC classification G01N33/5029. Mapped technology areas include Physics.
When was this patent published?
Publication date Thu Jan 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).